Study of AK131 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called AK131 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and can help slow or shrink the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an advanced solid tumor that has not responded to or is no longer helped by standard treatments, or no standard treatment exists.
- You are generally able to take care of yourself (fully active or able to do light work).
- You have at least one tumor that can be measured on a scan.
- Your liver, kidneys, and bone marrow are working well enough.
- If you could become pregnant, you agree to use effective birth control during the study and for 4 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called AK138D1 for people with advanced solid tumors. It aims to see if the drug is safe and how well it works, especially for tumors that haven't been treated with HER3-targeted therapy before.
This trial tests a new drug called AK137, which is a type of 'bispecific antibody' that targets two proteins (CD73 and LAG-3) to help your own immune system fight the cancer. It may be an option if your cancer has stopped responding to standard treatments.
This study tests an experimental drug (AK146D1) for people with advanced solid tumors that are no longer responding to standard treatments. The goal is to see if it is safe and effective.
This trial tests a new drug called AK138D1 for people with advanced solid tumors that have not responded to or can't tolerate standard treatments. The goal is to see if it is safe and effective.
This trial tests a new drug called AK146D1 for people with advanced solid tumors that have not responded to standard treatments or no longer work. The goal is to see if it is safe and effective.
This trial tests a new investigational drug (AK150) for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and effective in fighting the cancer.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.